Skip to main content
. 2015 Nov;3(20):309. doi: 10.3978/j.issn.2305-5839.2015.11.23

Figure 1.

Figure 1

Quantification of the BRAFV600E mutation in the plasma (A) and serum (B) of advanced stage melanoma patients, expressed in pg of mutated genome/µL of fluid. Patients are classified according to the number of metastatic sites.